Company page

Arcus Biosciences, Inc.

Arcus Biosciences, Inc. (ticker: RCUS) is a public company based in the United States, focusing on innovative cancer therapies. With a market capitalization of approximately $3.44 billion, Arcus is dedicated to advancing its research and development efforts in the biopharmaceutical sector. The company aims to improve treatment options for patients through its cutting-edge approaches in oncology.